Recombinant Erythropoietin Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: RC0411A19359EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Recombinant Erythropoietin in Global, including the following market information:

Global Recombinant Erythropoietin Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Recombinant Erythropoietin market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Erythropoietin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Erythropoietin Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Recombinant Erythropoietin Market Segment Percentages, By Type, 2020 (%)

• rhEPO
• Erythropoiesis-Stimulating Agents (ESA)

China Recombinant Erythropoietin Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Recombinant Erythropoietin Market Segment Percentages, By Application, 2020 (%)

• Chronic Kidney Disease
• Cancer Related Anemia
• Others

Global Recombinant Erythropoietin Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Recombinant Erythropoietin Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Recombinant Erythropoietin Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Recombinant Erythropoietin Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Amgen
• Johnson & Johnson
• Kyowa Hakko Kirin
• Roche
• 3SBio Group
• Celltrion, Inc
• Teva Pharmaceutical Industries Ltd
• F. Hoffmann-La Roche Ltd
• LG Life Sciences Ltd
• Biocon Limited
• Intas Pharmaceuticals Ltd
• Sun Pharmaceutical Industries Ltd
• Dr. Reddy's Laboratories Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant Erythropoietin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant Erythropoietin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT ERYTHROPOIETIN OVERALL MARKET SIZE

2.1 Global Recombinant Erythropoietin Market Size: 2021 VS 2027
2.2 Global Recombinant Erythropoietin Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Recombinant Erythropoietin Players in Global Market
3.2 Top Global Recombinant Erythropoietin Companies Ranked by Revenue
3.3 Global Recombinant Erythropoietin Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Erythropoietin Companies in Global Market, by Revenue in 2020
3.5 Global Companies Recombinant Erythropoietin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Erythropoietin Players in Global Market
  3.6.1 List of Global Tier 1 Recombinant Erythropoietin Companies
  3.6.2 List of Global Tier 2 and Tier 3 Recombinant Erythropoietin Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Recombinant Erythropoietin Market Size Markets, 2021 & 2027
  4.1.2 rhEPO
  4.1.3 Erythropoiesis-Stimulating Agents (ESA)
4.2 By Type - Global Recombinant Erythropoietin Revenue & Forecasts
  4.2.1 By Type - Global Recombinant Erythropoietin Revenue, 2016-2021
  4.2.2 By Type - Global Recombinant Erythropoietin Revenue, 2022-2027
  4.2.3 By Type - Global Recombinant Erythropoietin Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant Erythropoietin Market Size, 2021 & 2027
  5.1.2 Chronic Kidney Disease
  5.1.3 Cancer Related Anemia
  5.1.4 Others
5.2 By Application - Global Recombinant Erythropoietin Revenue & Forecasts
  5.2.1 By Application - Global Recombinant Erythropoietin Revenue, 2016-2021
  5.2.2 By Application - Global Recombinant Erythropoietin Revenue, 2022-2027
  5.2.3 By Application - Global Recombinant Erythropoietin Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant Erythropoietin Market Size, 2021 & 2027
6.2 By Region - Global Recombinant Erythropoietin Revenue & Forecasts
  6.2.1 By Region - Global Recombinant Erythropoietin Revenue, 2016-2021
  6.2.2 By Region - Global Recombinant Erythropoietin Revenue, 2022-2027
  6.2.3 By Region - Global Recombinant Erythropoietin Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Recombinant Erythropoietin Revenue, 2016-2027
  6.3.2 US Recombinant Erythropoietin Market Size, 2016-2027
  6.3.3 Canada Recombinant Erythropoietin Market Size, 2016-2027
  6.3.4 Mexico Recombinant Erythropoietin Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Recombinant Erythropoietin Revenue, 2016-2027
  6.4.2 Germany Recombinant Erythropoietin Market Size, 2016-2027
  6.4.3 France Recombinant Erythropoietin Market Size, 2016-2027
  6.4.4 U.K. Recombinant Erythropoietin Market Size, 2016-2027
  6.4.5 Italy Recombinant Erythropoietin Market Size, 2016-2027
  6.4.6 Russia Recombinant Erythropoietin Market Size, 2016-2027
  6.4.7 Nordic Countries Recombinant Erythropoietin Market Size, 2016-2027
  6.4.8 Benelux Recombinant Erythropoietin Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Recombinant Erythropoietin Revenue, 2016-2027
  6.5.2 China Recombinant Erythropoietin Market Size, 2016-2027
  6.5.3 Japan Recombinant Erythropoietin Market Size, 2016-2027
  6.5.4 South Korea Recombinant Erythropoietin Market Size, 2016-2027
  6.5.5 Southeast Asia Recombinant Erythropoietin Market Size, 2016-2027
  6.5.6 India Recombinant Erythropoietin Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Recombinant Erythropoietin Revenue, 2016-2027
  6.6.2 Brazil Recombinant Erythropoietin Market Size, 2016-2027
  6.6.3 Argentina Recombinant Erythropoietin Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Recombinant Erythropoietin Revenue, 2016-2027
  6.7.2 Turkey Recombinant Erythropoietin Market Size, 2016-2027
  6.7.3 Israel Recombinant Erythropoietin Market Size, 2016-2027
  6.7.4 Saudi Arabia Recombinant Erythropoietin Market Size, 2016-2027
  6.7.5 UAE Recombinant Erythropoietin Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Recombinant Erythropoietin Major Product Offerings
  7.1.4 Amgen Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.1.5 Amgen Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Recombinant Erythropoietin Major Product Offerings
  7.2.4 Johnson & Johnson Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.2.5 Johnson & Johnson Key News
7.3 Kyowa Hakko Kirin
  7.3.1 Kyowa Hakko Kirin Corporate Summary
  7.3.2 Kyowa Hakko Kirin Business Overview
  7.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Major Product Offerings
  7.3.4 Kyowa Hakko Kirin Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.3.5 Kyowa Hakko Kirin Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Recombinant Erythropoietin Major Product Offerings
  7.4.4 Roche Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.4.5 Roche Key News
7.5 3SBio Group
  7.5.1 3SBio Group Corporate Summary
  7.5.2 3SBio Group Business Overview
  7.5.3 3SBio Group Recombinant Erythropoietin Major Product Offerings
  7.5.4 3SBio Group Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.5.5 3SBio Group Key News
7.6 Celltrion, Inc
  7.6.1 Celltrion, Inc Corporate Summary
  7.6.2 Celltrion, Inc Business Overview
  7.6.3 Celltrion, Inc Recombinant Erythropoietin Major Product Offerings
  7.6.4 Celltrion, Inc Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.6.5 Celltrion, Inc Key News
7.7 Teva Pharmaceutical Industries Ltd
  7.7.1 Teva Pharmaceutical Industries Ltd Corporate Summary
  7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
  7.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Major Product Offerings
  7.4.4 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.7.5 Teva Pharmaceutical Industries Ltd Key News
7.8 F. Hoffmann-La Roche Ltd
  7.8.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.8.2 F. Hoffmann-La Roche Ltd Business Overview
  7.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Major Product Offerings
  7.8.4 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.8.5 F. Hoffmann-La Roche Ltd Key News
7.9 LG Life Sciences Ltd
  7.9.1 LG Life Sciences Ltd Corporate Summary
  7.9.2 LG Life Sciences Ltd Business Overview
  7.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Major Product Offerings
  7.9.4 LG Life Sciences Ltd Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.9.5 LG Life Sciences Ltd Key News
7.10 Biocon Limited
  7.10.1 Biocon Limited Corporate Summary
  7.10.2 Biocon Limited Business Overview
  7.10.3 Biocon Limited Recombinant Erythropoietin Major Product Offerings
  7.10.4 Biocon Limited Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.10.5 Biocon Limited Key News
7.11 Intas Pharmaceuticals Ltd
  7.11.1 Intas Pharmaceuticals Ltd Corporate Summary
  7.11.2 Intas Pharmaceuticals Ltd Business Overview
  7.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Major Product Offerings
  7.11.4 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.11.5 Intas Pharmaceuticals Ltd Key News
7.12 Sun Pharmaceutical Industries Ltd
  7.12.1 Sun Pharmaceutical Industries Ltd Corporate Summary
  7.12.2 Sun Pharmaceutical Industries Ltd Business Overview
  7.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Major Product Offerings
  7.12.4 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.12.5 Sun Pharmaceutical Industries Ltd Key News
7.13 Dr. Reddy's Laboratories Ltd
  7.13.1 Dr. Reddy's Laboratories Ltd Corporate Summary
  7.13.2 Dr. Reddy's Laboratories Ltd Business Overview
  7.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Major Product Offerings
  7.13.4 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Revenue in Global (2016-2021)
  7.13.5 Dr. Reddy's Laboratories Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Recombinant Erythropoietin Market Opportunities & Trends in Global Market
Table 2. Recombinant Erythropoietin Market Drivers in Global Market
Table 3. Recombinant Erythropoietin Market Restraints in Global Market
Table 4. Key Players of Recombinant Erythropoietin in Global Market
Table 5. Top Recombinant Erythropoietin Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Recombinant Erythropoietin Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Recombinant Erythropoietin Revenue Share by Companies, 2016-2021
Table 8. Global Companies Recombinant Erythropoietin Product Type
Table 9. List of Global Tier 1 Recombinant Erythropoietin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Erythropoietin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Recombinant Erythropoietin Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Recombinant Erythropoietin Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Recombinant Erythropoietin Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Recombinant Erythropoietin Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Recombinant Erythropoietin Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Recombinant Erythropoietin Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Recombinant Erythropoietin Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Recombinant Erythropoietin Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Recombinant Erythropoietin Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Recombinant Erythropoietin Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Recombinant Erythropoietin Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Recombinant Erythropoietin Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Recombinant Erythropoietin Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Recombinant Erythropoietin Revenue, (US$, Mn), 2022-2027
Table 30. Amgen Corporate Summary
Table 31. Amgen Recombinant Erythropoietin Product Offerings
Table 32. Amgen Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Recombinant Erythropoietin Product Offerings
Table 35. Johnson & Johnson Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 36. Kyowa Hakko Kirin Corporate Summary
Table 37. Kyowa Hakko Kirin Recombinant Erythropoietin Product Offerings
Table 38. Kyowa Hakko Kirin Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 39. Roche Corporate Summary
Table 40. Roche Recombinant Erythropoietin Product Offerings
Table 41. Roche Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 42. 3SBio Group Corporate Summary
Table 43. 3SBio Group Recombinant Erythropoietin Product Offerings
Table 44. 3SBio Group Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 45. Celltrion, Inc Corporate Summary
Table 46. Celltrion, Inc Recombinant Erythropoietin Product Offerings
Table 47. Celltrion, Inc Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 48. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 49. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offerings
Table 50. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 51. F. Hoffmann-La Roche Ltd Corporate Summary
Table 52. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Product Offerings
Table 53. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 54. LG Life Sciences Ltd Corporate Summary
Table 55. LG Life Sciences Ltd Recombinant Erythropoietin Product Offerings
Table 56. LG Life Sciences Ltd Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 57. Biocon Limited Corporate Summary
Table 58. Biocon Limited Recombinant Erythropoietin Product Offerings
Table 59. Biocon Limited Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 60. Intas Pharmaceuticals Ltd Corporate Summary
Table 61. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Product Offerings
Table 62. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 63. Sun Pharmaceutical Industries Ltd Corporate Summary
Table 64. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offerings
Table 65. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)
Table 66. Dr. Reddy's Laboratories Ltd Corporate Summary
Table 67. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Product Offerings
Table 68. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Erythropoietin Segment by Type
Figure 2. Recombinant Erythropoietin Segment by Application
Figure 3. Global Recombinant Erythropoietin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Recombinant Erythropoietin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Recombinant Erythropoietin Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Erythropoietin Revenue in 2020
Figure 8. By Type - Global Recombinant Erythropoietin Revenue Market Share, 2016-2027
Figure 9. By Application - Global Recombinant Erythropoietin Revenue Market Share, 2016-2027
Figure 10. By Region - Global Recombinant Erythropoietin Revenue Market Share, 2016-2027
Figure 11. By Country - North America Recombinant Erythropoietin Revenue Market Share, 2016-2027
Figure 12. US Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Recombinant Erythropoietin Revenue Market Share, 2016-2027
Figure 16. Germany Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 17. France Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Recombinant Erythropoietin Revenue Market Share, 2016-2027
Figure 24. China Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 28. India Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Recombinant Erythropoietin Revenue Market Share, 2016-2027
Figure 30. Brazil Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Recombinant Erythropoietin Revenue Market Share, 2016-2027
Figure 33. Turkey Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Recombinant Erythropoietin Revenue, (US$, Mn), 2016-2027
Figure 37. Amgen Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Johnson & Johnson Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Kyowa Hakko Kirin Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Roche Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. 3SBio Group Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Celltrion, Inc Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. LG Life Sciences Ltd Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Biocon Limited Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Revenue Year Over Year Growth (US$, Mn) & (2016-2021)